Expanded characterization of glycosylation abnormalities and galactose therapy in a patient with CCDC115-CDG using semi-quantitative N-glycan analysis of total and fractionated plasma glycoproteins, in response to Geerts et al. [1].

Yupeng Liu, Christina Lam, Sheri Poskanzer, Jenny Thies, Holly Stevens, Wenyue Zhang, Eva Morava, Miao He